117 Search Results

q=Lung

Search Again


Adam Alessio , PhD

Email: aalessio@uw.edu

Phone: (206) 543-2419

Dr. Alessio works with CT and PET cardiac perfusion imaging, protocol optimization for PET and CT, and tomographic image reconstruction problems with a particular interest in statistical issues regarding data analysis, organization, and reconstruction.

View Bio

David Au , MD, MS

Email: dau@uw.edu

Phone: (206) 764-2430

Dr. Au's research focuses on improving the quality and delivery of care for patients with chronic lung diseases, in particular, he is interested in primary pulmonary manifestations of tobacco smoke; COPD and lung cancer. His primary research focuses is on identifying and intervening upon potential gaps in the quality of care for patients with lung cancer and COPD. These gaps include a focus on the quality of end-of-life communication and care, delivery of high quality palliative care, heterogeneity in care, and whether health care delivery is concordant with best available evidence.

View Bio

Christina Baik , MD, MPH

Email: cbaik@fredhutch.org

Phone: (206) 288-7557

Dr. Baik's clinical interests are in lung, head and neck cancers. She is particularly interested in the development of molecular targeted therapies in lung cancer. Her research interests include: Targeted therapy in non-small cell lung cancer, immunotherapy, chemoprevention and identification of risk factors in non-small cell lung cancer particularly in never smokers, and the role of estrogen pathway in non-small cell lung cancers.

View Bio

Geoffrey Baird , MD, PhD

Email: gbaird@uw.edu

Phone: (206)744-9787

Dr. Baird's clinical interests include laboratory test utilization, molecular diagnostics, proteomics and immunohistochemistry. His group has developed a new proteomic technology for biomarker discovery in a range of diseases such as malignancies, cardiovascular disorders, and inflammatory conditions. One application of their technology is to discover protein expression changes associated with non-small cell lung cancer that have implications for diagnosis and treatment.

View Bio

Alice Berger , PhD

Email: ahberger@fredhutch.org

Phone: (206) 667-6281

The goal of the Berger laboratory is to enable precision medicine by systematically uncovering the molecular alterations in cancer, determining the function of these variant alleles, and understanding how these alleles modulate response to targeted or immune-based therapies. Although many of the genes involved in cancer have now been identified, a major challenge is discovering which specific alleles of these genes are involved and how these alleles modulate therapeutic response. We combine functional genomics, computational biology, biochemistry, and genetics to understand the mechanism of somatic cancer variants. Our goal is to identify drug targets and biomarkers and to translate this knowledge into clinical benefit for patients.

View Bio

Slobodan Beronja , PhD

Email: beronja@fredhutch.org

Phone: (206) 667-7609

Dr. Beronja's group studies molecular and cellular mechanisms essential for tissue growth during development and the formation of tumors. His goal is to identifying genes and gene pathways that can be used as targets in cancer therapy.

View Bio

Parveen Bhatti , PhD

Email: pbhatti@fredhutch.org

Phone: (206) 667-7803

Dr. Bhatti's research focus is on occupational and environmental epidemiology of cancer with a focus in biomarkers of exposure, susceptibility and disease; particularly genetic susceptibility to cancer following low dose exposure to occupational or medical ionizing radiation.

View Bio

C. Anthony (Tony) Blau , MD

Email: tblau@u.washington.edu

Phone: (206) 685-6873

Dr. Blau specializes in orchestrating collaborations across disparate scientific disciplines toward grand goals. As a physician-scientist he believes that our approach to cancer needs to be fundamentally restructured, and for this reason founded the UW's Center for Cancer Innovation (CCI). CCI applies the latest scientific knowledge to the treatment of today's cancer patients while using their experiences to benefit all cancer patients tomorrow. CCI recently launched its first clinical trial in an aggressive form of breast cancer called 'triple-negative' breast cancer. CCI is a grass-roots 'coalition of the willing,' comprised of nearly 100 community and academic oncologists, scientists, computational biologists, and other specialists from six different organizations, and owes much of its success to support from the South Sound region.

View Bio

Jesse Bloom , PhD

Email: jbloom@fredhutch.org

Phone: (206) 667-3622

Dr. Bloom studies the molecular evolution of proteins and viruses. Rapid evolution is a defining feature of many of the most medically problematic viral diseases, including influenza. Although this rapid evolution is usually bad from the perspective of public health, it offers a unique vantage from which to study a range of important questions in biology. His group takes an evolutionary perspective as we use a combination of experimental and computational techniques to study questions in virology, immunology, and protein biochemistry.

View Bio

Lynn Bonham , PhD

Email: lbonham@seattlecca.org

Phone: (206)288-2022

Dr. Bonham directs and manages Cellular Therapeutics at SCCA, which processes cells from peripheral blood, bone marrow and cord blood for standard transplantations and clinical trials for cancer treatment.

View Bio

Stephen Bowen , PhD

Email: srbowen@uw.edu

Phone: (206) 598-1128

Dr. Bowen's research focuses on quantitative molecular imaging of cancer and normal tissue for personalized radiation therapy. Specifically he is interested in machine learning of respiratory patterns for personalized motion management strategies during image acquisition, radiotherapy planning, and radiotherapy delivery; dose painting based on respiratory-gated FDG PET in NSCLC; and functional avoidance planning of both MAA and DTPA SPECT-defined lung regions in NSCLC and SC SPECT-defined liver regions in HCC.

View Bio

Ivana Bozic , PhD

Email: ibozic@uw.edu

Phone: (206) 543-5077

Dr. Bozic studies the evolution of cancer and its resistance to treatment through mathematical and computational modeling. Her interests lie in both theoretical aspects of these models and their application. On the theoretical side, Bozic studies stochastic processes, especially multi-type branching processes, and their finite time characteristics. Dr. Bozic collaborates extensively with experimental and clinical researchers to integrate modeling with clinical data, providing insight into the natural history of cancer in vivo.

View Bio

Roger Brent , PhD

Email: rbrent@fredhutch.org

Phone: (206) 667-1482

Dr. Brent studies the quantitative operation of the systems that living cells use to sense, represent, transmit, and act upon information to make decisions that determine their future fates. He specifically studies prototypic cell signaling systems in budding yeast and the pheromone response system; he has extended similar work to systems operating in single cells of tissues in a metazoan, Caenorhabditis elegans.

View Bio

James (Jim) Brinkley , MD, PhD

Email: brinkley@u.washington.edu

Phone: (206) 543-3954

Dr. Brinkley's primary research interest is biomedical informatics - the representation, management, sharing, visualization and utilization of neuroscience data and knowledge. He is the founder of the field of Structural Informatics, which has as its goal the development of methods for representing the structure of the body at multiple levels of detail, as for using these methods for organizing and integrating biomedical information. His aim is to find ways to represent the structure or the body in computer-readable form, and find ways to associate these representations with the myriad biomedical data that are available. His goal is to provide a structural information framework for integrating a huge variety of big and small biomedical data. Dr. Brinkley's projects have included anatomy education, brain mapping through the national Human Brain Project, cardiovascular data integration, clinical trials data integration through the national Clinical translational Science Awards, radiological image annotation and integration through the RadLex project, and craniofacial malformations data integration through the national FaceBase consortium. He is also interested in developing web-accessible computer applications utilizing these representations to solve practical problems in clinical medicine, research and education.

View Bio

Mac Cheever , MD

Email: mcheever@fredhutch.org

Phone: (206) 667-4141

Dr. Cheever's specialty is in the areas of medical oncology, immunotherapy and solid tumor research. His current research interests are in conducting cancer clinical trials to develop and test new immunotherapies. He also interested on developing the principles of T cell therapy, cancer antigen discovery and development of cancer vaccines, especially for breast cancer.

View Bio

Chu Chen , PhD, NRCC, DABCC

Email: cchen@fredhutch.org

Phone: (206) 667-6644

Dr. Chen's research interests include the identification of 1) diagnostic and prognostic markers to aid personalized management of head and neck cancer based on gene expression profiles, loss of heterozygosity, DNA copy number, and tissue microarray data.; and 2) determinants for the susceptibility to and survival from cancers of the head and neck, lung, endometrium, breast, prostate and testes through investigations into lifestyle factors, endogenous and environmental exposures, and genetic and epigenetic influences.

View Bio

Guang-Shing Cheng , MD

Email: cheng3@uw.edu

Phone: (206) 667-7074

Dr. Cheng specializes in pulmonary complications from bone marrow transplants and malignancies, unusual pulmonary infections. Her research focuses on improving outcomes for stem cell transplant patients with pulmonary complication and on advancing diagnostic strategies for early detection of lung cancer.

View Bio

Monique Cherrier , PhD

Email: cherrier@u.washington.edu

Phone: (206) 277-3594

Dr. Cherrier specializes in neuropsychology with a special interest in behavioral medicine, geriatrics, dementias and related disorders, and cancer and cancer-related cognitive dysfunction and rehabilitation. Currently she is examining the impact of cognitive training for cancer survivors, including neuroimaging.

View Bio

David Chhieng , MD, MBA, MSHI, MSEM, MA (HON)

Email: dchhieng@uw.edu

Phone: (206) 598-3315

Dr. Chhieng is director of Anatomic Pathology and a UW profession of pathology. He is surgical pathologist, with expertise in cytopathology, especially in performing and interpreting fine needle aspiration biopsy (FNA). Dr. Chhieng is board certified in Anatomic and Clinical Pathology, Cytopathology, and Clinical Informatics.

View Bio

Daniel Chiu , PhD

Email: chiu@u.washington.edu

Phone: (206) 543-1655

Dr. Chiu is a professor of engineering at UW whose research focus is on developing and applying single-molecule methods for probing complex biological systems, specifically synaptic functioning and single-cell biology. The Chiu group is interested in studying both the biophysical properties of single proteins in the context of a cell, as well as using the sensitivities achieved in single-molecule detection for biotechnological applications, such as in high-throughput screening, in the separation and detection of trace biological molecules from single cells (e.g., signaling proteins), and in the development of ultrasensitive sensors.

View Bio